300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Financial Services
Construction
Mobile
Non Profit
Clean Energy
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Facebook
Renewable Energy
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Blockchain
Real Estate
Sporting Goods
Music
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Taiwan
Zimbabwe
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Barbados
Belgium
Cyprus
Qatar
Austria
Azerbaijan
Ethiopia
Jordan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Belarus
Finland
Italy
Algeria
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Liechtenstein
Iceland
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Chris De Jonghe, Angel Investor at PMV

Chris De Jonghe

Angel Investor @ PMV

Netherlands, United States

Chris De Jonghe is a Series A investor at PMV in Netherlands focused on Biotechnology and Medical. Chris De Jonghe - Member, Group Management Committee @ Vinnof

Total investments:
3
Last investment:
Lead investor:
33%

Last updated:

Industries Chris De Jonghe invests in

BiotechnologyMedicalHealth CareTherapeuticsManufacturing

Stages Chris De Jonghe invests in

Series ASeries B

Countries Chris De Jonghe invests in

BelgiumThe Netherlands

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 2 (67%)
  • Medical 1 (33%)
  • Health Care 1 (33%)
  • Therapeutics 1 (33%)
  • Manufacturing 1 (33%)
See all 6 industries →

Stage

  • Series A 1 (33%)
  • Series B 1 (33%)

Country

  • Belgium 1 (33%)
  • The Netherlands 1 (33%)

Investments

CompanyDescriptionRoundLinks
Immagene develops personalized cancer immunotherapies to fight multiple cancer type. $21.4M / Series A / Apr 24, 2024
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models.They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugscurrently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept. $14.6M / Series B / Jan 21, 2021
Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models.They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugscurrently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept. $13.7M / Series B / Dec 18, 2018

Co-Investors

PMV

About PMV

VC Fund · Brussels, Belgium

PMV is a do and dare company that is shaping the future of the Flemish economy. It provides funding for promising companies' businesses, from the day they first open their doors, through their various growth stages and even on to operating internationally. Working with and for the government and other partners, PMV implements projects that are important for prosperity and well-being in Flanders. PMV is convinced that entrepreneurship is crucial for the development of a prosperous future for Flanders and everyone who lives there. It firmly believes that every promising enterprise project in Flanders needs to find funding – but also that every business needs to be profitable in order to be sustainable. Which is why PMV and the companies and projects in which it invests must be profitable in the end.

PMV Contacts

NameEmailPhoneSocials
Stefan De Waele
Stefan De Waele Senior Investment Manager
Bart De Taeye
Bart De Taeye Investment Director
Christine Claus
Christine Claus Director
Clair Ysebaert
Clair Ysebaert Director
Diane Lejeune
Diane Lejeune Senior Investment Manager, Life Sciences and Care

Sign up to unlock verified contacts

Unlock Contacts

See all 15 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Financial Services
Construction
Mobile
Non Profit
Clean Energy
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Facebook
Renewable Energy
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Blockchain
Real Estate
Sporting Goods
Music
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Taiwan
Zimbabwe
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Barbados
Belgium
Cyprus
Qatar
Austria
Azerbaijan
Ethiopia
Jordan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Belarus
Finland
Italy
Algeria
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Liechtenstein
Iceland
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Chris De Jonghe invest in?

Chris De Jonghe invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Chris De Jonghe?

Public channels for Chris De Jonghe include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Chris De Jonghe last invest?

The most recent investment recorded for Chris De Jonghe closed in Apr 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Chris De Jonghe Chris De Jonghe Find email